Literature DB >> 11317648

Bleeding tendency in Wolfram syndrome: a newly identified feature with phenotype genotype correlation.

M al-Sheyyab1, N Jarrah, E Younis, M M Shennak, A Hadidi, A Awidi, H el-Shanti, K Ajlouni.   

Abstract

Wolfram syndrome (WS) is a recessively inherited disorder associated with recognised clinical features. Bleeding tendency was noticed in some of our patients, although this has not been reported before. We therefore studied this problem in all our WS patients and tried to postulate a possible pathogenesis. At the same time, a genetic linkage study provided evidence of locus heterogeneity of this syndrome and showed that the majority of our patients belong to the second WS locus identified in that study. Our study group consisted of 13 WS patients, belonging to WSF2 locus (group I). Controls consisted of 4 healthy siblings of WS patients (group II) and 7 diabetics who do not have WS (group III). Relevant clinical data were obtained, and a coagulation screen was carried out for all groups. All individuals in the three study groups have normal platelet count, thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (aPTT), clot retraction, Factor VIII activity (FVIIIc) and von Willebrand factor antigen (vWAg). Eleven of the WS patients have prolonged template bleeding time (BT) compared with both control groups. Patients with WS have a longer BT (mean 9.6 min, 95% CL 8.61-10.53 min) than the siblings group (mean 6.75 min, 95% CL 5.52-7.98 min) and the diabetic group (mean 5.49 min, 95% CL 4.56-6.42 min). The differences between the study group and controls are statistically significant, p = 0.02 and 0.0002, respectively. In the three groups, platelet aggregation studies were normal using adenosine diphosphate (ADP), ristocetin and epinephrine. Aggregation with collagen was either absent or impaired, with failure of secondary wave being noticed in 11 of the WS patients (85%) and normal in the control groups. The pathogenesis of this problem is not known, but could be due to an inhibitory effect of vWAgII, deficiency of thrombospondin or a defect in the platelet membrane GPIa/IIa. Bleeding diathesis is a new additional feature to the clinical spectrum of WS, which is probably a feature of the disorder WFS2 and not WFS1, as bleeding has never been reported in the latter. This provides further evidence for the phenotypic and genotypic heterogeneity of this complex disorder and may provide clues to the search for the second gene responsible for this phenotype.

Entities:  

Mesh:

Year:  2001        PMID: 11317648     DOI: 10.1007/s004310000704

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  [Bilateral optic nerve atrophy in an 18-year-old female patient with diabetes mellitus].

Authors:  Jonathan Hall; Teresa Neuhann; Felix Treumer; Thomas Neuhann; Irmingard Neuhann
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

Review 2.  Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease.

Authors:  Luciana Rigoli; Placido Bramanti; Chiara Di Bella; Filippo De Luca
Journal:  Pediatr Res       Date:  2018-02-28       Impact factor: 3.756

3.  The novel compound heterozygous mutations, V434del and W666X, in WFS1 gene causing the Wolfram syndrome in a Chinese family.

Authors:  Jie Hong; Yu-Wen Zhang; Hui-Jie Zhang; Hui-Ying Jia; Yu Zhang; Xiao-Yi Ding; Dan-Yang Zhou; Hui-Ping Chen; Xiao-Hua Jiang; Bin Cui; Xiao-Ying Li; Guang Ning
Journal:  Endocrine       Date:  2009-01-22       Impact factor: 3.633

4.  A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2.

Authors:  Sami Amr; Cindy Heisey; Min Zhang; Xia-Juan Xia; Kathryn H Shows; Kamel Ajlouni; Arti Pandya; Leslie S Satin; Hatem El-Shanti; Rita Shiang
Journal:  Am J Hum Genet       Date:  2007-08-20       Impact factor: 11.025

Review 5.  Clinical Spectrum Associated with Wolfram Syndrome Type 1 and Type 2: A Review on Genotype-Phenotype Correlations.

Authors:  Maurizio Delvecchio; Matteo Iacoviello; Antonino Pantaleo; Nicoletta Resta
Journal:  Int J Environ Res Public Health       Date:  2021-04-30       Impact factor: 3.390

6.  Wolfram Syndrome: A Case Report and Review of Clinical Manifestations, Genetics Pathophysiology, and Potential Therapies.

Authors:  N B Toppings; J M McMillan; P Y B Au; O Suchowersky; L E Donovan
Journal:  Case Rep Endocrinol       Date:  2018-04-18

7.  The mitochondrial localized CISD-3.1/CISD-3.2 proteins are required to maintain normal germline structure and function in Caenorhabditis elegans.

Authors:  Skylar D King; Chipo F Gray; Luhua Song; Ron Mittler; Pamela A Padilla
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

8.  Clinical utility gene card for: Wolfram syndrome.

Authors:  Mariya Moosajee; Patrick Yu-Wai-Man; Cécile Rouzier; Maria Bitner-Glindzicz; Richard Bowman
Journal:  Eur J Hum Genet       Date:  2016-05-25       Impact factor: 4.246

9.  A novel CISD2 intragenic deletion, optic neuropathy and platelet aggregation defect in Wolfram syndrome type 2.

Authors:  Enza Mozzillo; Maurizio Delvecchio; Massimo Carella; Elvira Grandone; Pietro Palumbo; Alessandro Salina; Concetta Aloi; Pietro Buono; Antonella Izzo; Giuseppe D'Annunzio; Gennaro Vecchione; Ada Orrico; Rita Genesio; Francesca Simonelli; Adriana Franzese
Journal:  BMC Med Genet       Date:  2014-07-24       Impact factor: 2.103

Review 10.  Developmental hypomyelination in Wolfram syndrome: new insights from neuroimaging and gene expression analyses.

Authors:  Amjad Samara; Rachel Rahn; Olga Neyman; Ki Yun Park; Ahmad Samara; Bess Marshall; Joseph Dougherty; Tamara Hershey
Journal:  Orphanet J Rare Dis       Date:  2019-12-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.